Last updated on August 2018

Randomized Study of CX-01 Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute myeloid leukemia
  • Age: Between 60 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Newly diagnosed, de novo or secondary, previously untreated AML
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2

Exclusion Criteria:

  • Acute promyelocytic leukemia
  • Prior chemotherapy for AML
  • Prior intensive chemotherapy or stem cell transplantation for the treatment of myelodysplastic syndrome
  • CNS leukemia

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.